JJ
Johnson John
Chief Executive Officer
C-suiteM
Insider track record
CEONot enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the full record of transactions filed by Johnson John, Chief Executive Officer. Insider active across 6 companies, notably Strongbridge Biopharma plc. Aggregated, 22 reports have been recorded. Breakdown: 0 buy · 4 sells. Total volume traded: €1.9m. History available since 2 July 2021. The latest transaction was filed on 19 December 2025 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Johnson John
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations22 total
14,150 sharesCommon StockSEC:0001410781-26-000006:0
135,400 shares@ US$7.215843.9% of flowCommon StockSEC:0001410781-25-000006:0
11,802 shares@ US$31.2689.3% of flowCommon StockSEC:0001410781-25-000004:0
107,500 shares@ US$7.315963.0% of flowCommon StockSEC:0001867096-25-000141:0
4,073 shares@ US$10.61100.0% of flowCommon StockSEC:0000805928-25-000081:0
50,000 shares0Common StockSEC:0001867096-25-000108:0
8,333 shares0Common StockSEC:0001104659-25-053093:0
500,000 shares0Common StockSEC:0000950170-24-139240:0
11,904 shares0Common StockSEC:0000805928-24-000121:0
8,333 shares0Common StockSEC:0001104659-24-073599:0
10,653 sharesCommon StockSEC:0000805928-24-000099:0
50,000 shares0Common StockSEC:0001867096-24-000106:0
89,571 sharesCommon StockSEC:0001867096-24-000039:0
215,600 shares@ US$1.99100.0% of flowCommon StockSEC:0001867096-24-000036:0
42,500 shares0Common StockSEC:0001867096-23-000099:0
6,459 shares0Common StockSEC:0000805928-23-000066:0
15,000 shares0Common StockSEC:0001867096-22-000090:0
478,312 sharesCommon StockSEC:0000899243-21-039749:0
610,092 sharesOrdinary SharesSEC:0001179110-21-009282:0
334,868 shares@ US$2.0681.8% of flowOrdinary SharesSEC:0001179110-21-009224:0
478,312 sharesCommon StockSEC:0000899243-21-039341:0
50,867 shares@ US$3.0818.2% of flowOrdinary SharesSEC:0001179110-21-007439:0
About Johnson John
JOHNSON JOHN is Directeur Général. He has been linked to 22 filings in total, and across the 22 sampled filings between 2021-07-07 and 2026-06-23, sales total 1859438 EUR and buys total 0 EUR. His listed companies are Xeris Biopharma Holdings, Inc., Axogen, Inc., Strongbridge Biopharma plc, Verastem, Inc. and Applied Therapeutics, Inc.